Texas Attorney General Sues Tylenol Makers Over Autism Spectrum Assertions

Courtroom Proceedings
The Texas Attorney General, who supports former President Trump who is running for US Senate, alleged the drug companies of concealing safety concerns of acetaminophen

The top legal official in Texas Paxton is filing a lawsuit against the producers of acetaminophen, claiming the corporations hid potential risks that the drug posed to pediatric brain development.

This legal action arrives thirty days after Donald Trump advocated an unverified association between consuming acetaminophen - also known as paracetamol - during pregnancy and autism spectrum disorder in children.

Paxton is filing suit against the pharmaceutical giant, which formerly manufactured the drug, the sole analgesic approved for expectant mothers, and Kenvue, which presently makes it.

In a declaration, he said they "betrayed America by profiting off of suffering and marketing drugs without regard for the risks."

Kenvue says there is no credible evidence tying acetaminophen to autism spectrum disorder.

"These corporations misled for generations, knowingly endangering countless individuals to line their pockets," Paxton, a Republican, declared.

The company stated officially that it was "seriously troubled by the spread of false claims on the safety of paracetamol and the likely effects that could have on the well-being of women and children in America."

On its website, the company also said it had "regularly reviewed the applicable studies and there is no credible data that demonstrates a proven link between using acetaminophen and autism."

Associations acting on behalf of doctors and health professionals share this view.

ACOG has declared paracetamol - the primary component in Tylenol - is a restricted selection for expectant mothers to manage discomfort and fever, which can create major wellness concerns if left untreated.

"In more than two decades of studies on the utilization of acetaminophen in gestation, zero credible investigations has definitively established that the consumption of acetaminophen in any period of pregnancy causes neurodevelopmental disorders in children," the association stated.

This legal action mentions recent announcements from the previous government in asserting the drug is potentially dangerous.

In recent weeks, Trump generated worry from public health officials when he instructed pregnant women to "resist strongly" not to consume acetaminophen when unwell.

The US Food and Drug Administration then released a statement that doctors should think about restricting the use of Tylenol, while also stating that "a proven link" between the drug and autism in young ones has remains unverified.

Health Secretary Kennedy, who supervises the Food and Drug Administration, had pledged in spring to undertake "a massive testing and research effort" that would determine the source of autism spectrum disorder in a limited time.

But specialists warned that discovering a unique factor of autism - considered by experts to be the consequence of a complicated interplay of inherited and surrounding conditions - would not be simple.

Autism spectrum disorder is a form of enduring cognitive variation and impairment that affects how individuals encounter and interact with the surroundings, and is recognized using medical professional evaluations.

In his lawsuit, Paxton - who supports Trump who is running for the Senate - alleges the manufacturer and Johnson & Johnson "deliberately disregarded and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.

This legal action aims to force the corporations "destroy any promotional materials" that asserts Tylenol is safe for pregnant women.

The Texas lawsuit parallels the concerns of a collection of parents of young ones with autism and ADHD who took legal action against the producers of acetaminophen in 2022.

The court threw out the legal action, stating research from the parents' expert witnesses was lacking definitive proof.

Emily Lopez
Emily Lopez

A tech enthusiast and writer with a passion for exploring emerging technologies and their impact on everyday life.